Mugwort's Emmenagogue Tradition and the Case for Avoiding It in Pregnancy

Uterine smooth muscle, the tissue at the centre of the question
Uterine smooth muscle, the tissue at the centre of the question
Mugwort leaf, dark green above and silvery below
Mugwort leaf, dark green above and silvery below
Mugwort tea, the oral form at issue in pregnancy
Mugwort tea, the oral form at issue in pregnancy

This page contains a pregnancy safety warning: the research and the standard herbal-safety classification both raise a strong concern about mugwort taken internally — as tea, tincture, capsule, or any other oral preparation — during pregnancy or while trying to become pregnant. That warning is not new information; it appears on the main Mugwort page already. What this page adds is the case for it: where the "women's herb" tradition actually comes from, what the real pharmacology shows about how mugwort acts on reproduction, and why several independent lines of evidence — not just one fragile data point — converge on the same caution.

Table of Contents

  1. A Cross-Cultural Tradition, Not a Local Folk Belief
  2. What the Name Mugwort Does and Does Not Say
  3. What the Real Pharmacology Shows: Not a Simple "Uterine Stimulant"
  4. A Tissue Caveat: Vessel Data Is Not Uterine Data
  5. Thujone: A Second, Independent Mechanism for Concern
  6. The Counter-Point: One Isolated Compound Tested Safe on the Uterus
  7. How Regulatory and Reference Bodies Classify the Risk
  8. Why Moxibustion for Breech Presentation Is a Different Question
  9. The Bottom Line
  10. Key Research Papers
  11. Connections
  12. Featured Videos

A Cross-Cultural Tradition, Not a Local Folk Belief

Mugwort's reputation as a "women's herb" is not a single regional folk belief that happened to survive; it is one of the most consistently recurring traditional uses of the plant across unrelated cultures. A 2014 meta-analysis of medicinal plants used for women's healthcare across Southeast Asia, reviewing roughly 200 separate ethnobotanical studies covering nearly 2,000 plant species used in over 5,000 documented preparations, found Artemisia vulgaris among the small handful of species — alongside better-known names like turmeric, castor, and hibiscus — cited in more than ten independent scientific articles for uses spanning increasing or regulating menstruation, easing labor and the postpartum period, and managing pregnancy-related complaints.[2] A separate comprehensive review of mugwort's history in medicine documents the same emmenagogue and uterine tradition across Europe, going back centuries, independent of the Southeast Asian record.[3] This is exactly the kind of broad, geographically independent convergence that makes a traditional use worth taking seriously as a real biological signal, even before any laboratory data exists — two populations who never exchanged herbal knowledge reaching for the same plant, for related reasons, is evidence in its own right.

It is also, notably, a tradition that cuts both ways depending on what a reader wants from it. The same plant is described as something to use to bring on a delayed period, to ease labor, and to avoid entirely during pregnancy — three traditional instructions that only make sense together if mugwort is understood as a herb that acts on the uterus and reproductive hormones, with the specific effect (stimulating, timing labor, or risking miscarriage) depending on dose, timing, and the state of the uterus when it is taken. That is a coherent picture, and the traditional warning against use in pregnancy is the part of this tradition that the laboratory evidence below supports most directly.

Back to Table of Contents

What the Name Mugwort Does and Does Not Say

One specific trap is worth checking: a traditional plant name can smuggle in a safety implication that then biases how the folk evidence is read. The clearest case elsewhere on this site is motherwort, whose name literally means "acts on the uterus" and is exactly why it is contraindicated in pregnancy — the name is not a coincidence, it is the finding, stated in Old English. It is worth checking directly whether "mugwort" is doing the same thing, rather than assuming it by association with a similarly-named plant.

It is not, at the species level. "Mugwort" itself most plausibly derives from Old English roots connected to moths (the plant was used to repel them from stored clothing and grain) or from a word for a biting midge, and the plant's other English folk names — felon herb, St. John's plant, chrysanthemum weed, cronewort — describe its appearance, its midsummer festival associations, or old age (a "crone"), not a uterine action. None of them reads as an outcome claim the way "motherwort" or Cissus's Hindi name hadjod ("bone-joiner") do.

The genus name is a different, more interesting case, and worth stating with appropriate uncertainty rather than as settled fact. Artemisia is conventionally traced to Artemis, the Greek goddess who presided over both the hunt and childbirth — and one classical tradition holds that Artemisia plants were named for her specifically because of their use in women's reproductive complaints, while another holds the name honors Artemisia II of Caria, a botanist-queen. Which explanation is historically correct is genuinely disputed, and this page does not have a way to settle it. What can be said honestly is that if the childbirth-goddess etymology is the real one, the entire genus — not just mugwort specifically — carries a very old, built-in association with reproduction that would apply equally to every Artemisia species regardless of its actual pharmacology, which is itself a reason not to lean too heavily on etymology as evidence either way.

Back to Table of Contents

What the Real Pharmacology Shows: Not a Simple "Uterine Stimulant"

Popular herbal references tend to flatten mugwort's reproductive effects into a single phrase — "uterine stimulant" — and some secondary sources describe the opposite, calling it a "uterine relaxant" or "uterine sedative" on the strength of its volatile-oil antispasmodic constituents. Both cannot be the plant's primary action, and reporting only one would be picking the flattering half of a real contradiction. The actual primary-literature pharmacology, thin as it is, points to something more specific than either simple label.

The most directly relevant study is a 2014 paper by Shaik and colleagues testing a methanolic extract of Artemisia vulgaris leaves in female Wistar rats.[1] At oral doses of 300 and 600 mg/kg, the extract produced a complete (100%) reduction in implant formation — a strong antifertility effect by preventing embryo implantation rather than by directly provoking uterine contraction. When the same extract was tested in ovariectomized immature rats, a standard assay for estrogenic activity, it produced a significant increase in uterine weight, the classic sign of estrogenic stimulation. Put together, this study points toward an estrogenic / anti-implantation mechanism — the extract behaving like it is disrupting the hormonal signaling implantation depends on — rather than a simple oxytocin-like "makes the uterus squeeze" story. That mechanism is at least broadly consistent with mugwort's documented flavonoid content: eriodictyol and apigenin, both present in the plant, have known weak estrogenic activity in other contexts, which gives the antifertility finding a plausible chemical basis rather than leaving it as an isolated, unexplained result.

An earlier rat study points the same way. In 1994, Narwaria and colleagues in Varanasi, India, gave an alcoholic extract of the plant's aerial parts (leaves, stems and flowers) to female albino rats.[12] Over the 18-day test period the extract made the estrous (heat) cycle irregular, and it showed 80% anti-implantation activity. Pups that were born showed no gross malformations, even at a high oral dose of 3,000 mg/kg.

These are two rat studies, not a body of confirmatory work, and this page is not going to overstate them. But they are real, single-species (not pooled across the genus the way some ethnobotanical reviews are), quantified, and it points toward a genuine, biologically coherent mechanism for reproductive harm — which is a meaningfully stronger basis for caution than "tradition says so" alone, even though tradition here happens to agree.

Back to Table of Contents

A Tissue Caveat: Vessel Data Is Not Uterine Data

One more piece of Artemisia vulgaris smooth-muscle pharmacology is worth mentioning here, with an explicit caveat about what it does and does not show. A 2016 study by Nguyen and colleagues investigated why Vietnamese traditional herbalists disagree about whether mugwort helps or worsens hypertension, by testing extract effects on isolated porcine basilar artery (a blood vessel supplying the brainstem).[4] The extract produced both vasoconstriction (partly serotonin-receptor mediated) and, under different starting conditions, vasorelaxation — a genuinely bidirectional effect that the authors argue explains the conflicting folk opinions about the plant and blood pressure.

That finding is included here for a specific, limited reason: it demonstrates that Artemisia vulgaris extract can act on smooth muscle in opposite directions depending on tissue state, which is a useful general caution against assuming any single, simple story for how this plant acts on any smooth muscle, including the uterus. But a cerebral artery is not a uterus, and this study says nothing directly about uterine tissue — citing it as if it did would be exactly the kind of tissue substitution this site's evidence doctrine flags elsewhere (an osteoblast result is not a chondrocyte result; a basilar-artery result is not a uterine result). It is context for why "simple stimulant" is probably the wrong mental model, not itself evidence about pregnancy risk.

Back to Table of Contents

Thujone: A Second, Independent Mechanism for Concern

The estrogenic/anti-implantation mechanism above is not the only reason for concern about mugwort in pregnancy, and that matters: when two mechanistically unrelated concerns point the same direction, the overall case is stronger than either alone, because it does not depend on any single study being right. The essential-oil deep-dive on this site covers thujone chemistry and toxicity in full detail; the short version relevant here is that mugwort's volatile oil contains thujone at genuinely variable but sometimes substantial concentrations, and thujone is a well-characterized neuroactive compound that antagonizes gamma-aminobutyric acid-A receptors — the same inhibitory receptor system that anticonvulsant drugs enhance — a mechanism established in a landmark 2000 study of pure alpha-thujone, the active component of absinthe.[7] A companion study by an overlapping author group found marked differences between species — and in which part of the molecule gets oxidized — when cytochrome P450 enzymes break thujone down (detoxify it), comparing mouse, rat and human liver preparations and dosed mice and rats.[9] That study did not compare individual people and did not study the fetus; the idea that a developing fetus, with immature detoxification enzymes, could handle thujone differently from its mother is an inference, not a finding of the paper. Both mechanism papers studied pure thujone (the active component of absinthe, which is made from a different species, wormwood, A. absinthium), so they are cited here only for what thujone the molecule does once absorbed — a property of the compound, not of one particular plant — not as species-specific mugwort evidence; the essential-oil page documents that Artemisia vulgaris itself, not just its wormwood relative, has caused a documented human thujone-poisoning case from tea. Separately, a 2022 test-tube study found that acetone and water extracts of Artemisia vulgaris raised the rate of micronuclei (a sign of chromosome damage) in human white blood cells (lymphocytes) at every concentration tested, 10–250 µg/mL for the water extract; the authors examined the extracts' polyphenol content as a possible explanation, and the study did not test the volatile oil or thujone.[8] A broader 2019 review of mugwort's therapeutic potential and underlying mechanisms situates this alongside the plant's other, non-reproductive bioactivity.[10] A neuroactive volatile-oil constituent that could reach a developing fetus is a second, chemically independent reason for caution that has nothing to do with the estrogenic/antifertility mechanism above — two different pathways, both pointing toward the same pregnancy concern. (The genotoxicity result belongs to whole extracts tested in a test tube, not to thujone, and shows nothing directly about the fetus.)

Back to Table of Contents

The Counter-Point: One Isolated Compound Tested Safe on the Uterus

In fairness, and because refusing to manufacture hazards matters as much as naming real ones, one 2025 study deserves mention precisely because it does not support alarm. Singh and colleagues isolated a compound called isosecotanapartholide from Artemisia vulgaris — being investigated as a natural insecticide, unrelated to thujone or the plant's reproductive tradition — and tested it for acute and sub-acute oral toxicity in mice at doses up to 1,600 mg/kg.[5] Across every organ examined, including the uterus specifically, no adverse effects or mortality were observed at any tested dose.

This is worth stating plainly rather than omitting: not every compound in mugwort is a reproductive hazard, and this particular one, at least, cleared the uterus specifically in a real toxicology study. It does not change the overall picture, because the antifertility/estrogenic evidence above used a whole methanolic leaf extract (not this one isolated compound) and the thujone concern is about a completely different constituent. One ingredient testing clean does not clear the whole plant, any more than one ingredient testing badly would condemn it — but it is a real, honest data point, and leaving it out would understate what is actually known.

Back to Table of Contents

How Regulatory and Reference Bodies Classify the Risk

The Botanical Safety Handbook, the standard cross-referenced safety classification system used by clinical herbalists and toxicologists in the United States, places mugwort in Safety Class 2b: not to be used in pregnancy, specifically because of its emmenagogue and uterine-stimulant reputation. That classification is a synthesis of exactly the kind of evidence this page describes — centuries of independent cross-cultural traditional use, documented case reports of adverse reproductive effects (including reports of strong uterine contractions and, in some cases, pregnancy loss associated with ingestion), and biological plausibility from related Artemisia pharmacology — rather than a single randomized trial, because no ethics board would approve a trial testing whether mugwort causes miscarriage. That is worth understanding about how this kind of classification works at all: a traditional-use-plus-plausibility instrument, not an efficacy trial, is not weaker evidence for a safety question the way it would be for a benefit claim — withholding a substance from pregnant people does not require proving harm to modern trial standards; it requires only a credible signal, and mugwort has several, from independent directions.

Back to Table of Contents

Why Moxibustion for Breech Presentation Is a Different Question

The hub page and the dedicated moxibustion deep-dive both cover a use of mugwort that specifically happens during pregnancy: burning moxa near an acupuncture point on the little toe, late in the third trimester, to encourage a breech baby to turn. This is not a contradiction of the pregnancy warning on this page, and it is worth being explicit about why. Moxibustion for breech presentation is an external, localized, professionally-timed procedure that does not involve ingesting any part of the plant — no estrogenic extract, no thujone-bearing oil crosses the gut wall or the placenta from smoke held near a toe. In practice it is done under midwifery or obstetric supervision, at a specific gestational window, using an external heat-and-smoke exposure that is a fundamentally different route of administration from drinking mugwort tea or taking a tincture. The concern about mugwort taken internally in pregnancy and the offer of supervised external moxibustion late in pregnancy for breech presentation both hold at the same time, for the same plant, because route of administration is not a detail here — it is the entire difference between the two claims.

The 2023 Cochrane review of moxibustion for breech presentation (13 trials, 2,181 women) found that moxibustion added to usual care probably lowers the chance of the baby still not lying head-down at birth (7 trials, 1,152 women; risk ratio 0.87, 95% confidence interval 0.78–0.99; moderate-certainty evidence).[13] It probably makes little or no difference to the caesarean-section rate (6 trials, 1,030 women; risk ratio 0.94). Side effects such as nausea, the unpleasant smell, abdominal pain and uterine contractions were poorly reported in most trials, so the review was very uncertain about them.

Back to Table of Contents

The Bottom Line

Mugwort's reputation as a menstrual-regulating "women's herb" is one of the most consistent traditional uses of the plant worldwide, and unlike some herbs on this site, its common English names do not smuggle in a hidden safety message the way "motherwort" does — the case for caution here rests on the evidence itself, not on etymology. That evidence, thin as direct human trial data is, converges from multiple independent angles: two rat studies showing a strong estrogenic/anti-implantation effect from whole-plant extracts; a chemically unrelated neurotoxicity concern from thujone in the essential oil; centuries of cross-cultural tradition explicitly warning against use in pregnancy; and a formal safety classification built on exactly that combination of signals. None of these alone would be conclusive. Together, they underlie the Botanical Safety Handbook's Class 2b listing (not to be used in pregnancy), and the caution on this page and the main Mugwort page covers mugwort taken internally during pregnancy in any form, including doses believed to be small.

Back to Table of Contents

Key Research Papers

  1. Shaik A, Kanhere RS, Cuddapah R, Nelson KS, Vara PR, Sibyala S. Antifertility activity of Artemisia vulgaris leaves on female Wistar rats. Chinese Journal of Natural Medicines. 2014;12(3):180-185. — PubMed PMID: 24702803 — the core primary evidence: 100% anti-implantation and estrogenic activity in rats.
  2. de Boer HJ, Cotingting C. Medicinal plants for women's healthcare in southeast Asia: a meta-analysis of their traditional use, chemical constituents, and pharmacology. Journal of Ethnopharmacology. 2014;151(2):747-767. — PubMed PMID: 24269772 — cross-cultural traditional-use meta-analysis, ~200 studies.
  3. Ekiert H, Pajor J, Klin P, Rzepiela A, Šlesak H, Szopa A. Significance of Artemisia Vulgaris L. (Common Mugwort) in the History of Medicine and Its Possible Contemporary Applications Substantiated by Phytochemical and Pharmacological Studies. Molecules. 2020;25(19):4415. — PubMed PMID: 32992959 — broad review documenting the European emmenagogue tradition.
  4. Nguyen HT, Nguyen HT, Islam MZ, et al. Pharmacological characteristics of Artemisia vulgaris L. in isolated porcine basilar artery. Journal of Ethnopharmacology. 2016;182:16-26. — PubMed PMID: 26875644 — bidirectional smooth-muscle pharmacology; vascular tissue, cited with an explicit tissue caveat.
  5. Singh NB, Singh KD, Koijam AS, et al. Toxicological evaluation of Isosecotanapartholide from Artemisia vulgaris L.: oral acute and sub-acute toxicity in BALB/c mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(9):12701-12711. — PubMed PMID: 40208317 — one isolated compound tested safe on the uterus specifically; does not clear the whole plant.
  6. Abiri R, Silva ALM, de Mesquita LSS, et al. Towards a better understanding of Artemisia vulgaris: Botany, phytochemistry, pharmacological and biotechnological potential. Food Research International. 2018;109:403-415. — PubMed PMID: 29803465 — comprehensive phytochemistry review, including flavonoid content (eriodictyol, apigenin).
  7. Höld KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences. 2000;97(8):3826-3831. — PubMed PMID: 10725394 — landmark thujone-GABA mechanism paper; studied pure alpha-thujone (the active component of absinthe), cited only for thujone's general chemical mechanism.
  8. Radović Jakovljević M, Stanković M, Vuković N, Vukić M, Grujičić D, Milošević-Djordjević O. Comparative study of the genotoxic activity of Artemisia vulgaris L. and Artemisia alba Turra extracts in vitro. Drug and Chemical Toxicology. 2022;45(4):1915-1922. — PubMed PMID: 34844486 — acetone and water extracts tested on human lymphocytes in a test tube; the volatile oil and thujone were not tested.
  9. Höld KM, Sirisoma NS, Casida JE. Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chemical Research in Toxicology. 2001;14(5):589-595. — PubMed PMID: 11368559 — site and species differences in thujone clearance (mouse, rat, human liver preparations); compound-level mechanism, not vulgaris-specific.
  10. Soon L, Ng PQ, Chellian J, et al. Therapeutic potential of Artemisia vulgaris: An insight into underlying immunological mechanisms. Journal of Environmental Pathology, Toxicology and Oncology. 2019;38(3):205-216. — PubMed PMID: 31679308 — broader review of the plant's bioactivity and mechanisms.
  11. Aksoy T, Girginkardešler N, Balcıoğlu İC, Kilimcioğlu AA. Antiprotozoal Activity of Artemisia vulgaris and Berberis vulgaris Against Leishmania major and Trichomonas vaginalis. Acta Parasitologica. 2026;71(1):44. — PubMed PMID: 41697430 — illustrates the extract's broader, non-reproductive bioactivity profile.
  12. Narwaria A, Khosa RL, Dhar SK. Experimental studies on artemisia vulgaris - a possible antifertility drug. Ancient Science of Life. 1994;14(1-2):10-15. — PubMed PMID: 22556669 — second rat study: irregular estrous cycle and 80% anti-implantation activity.
  13. Coyle ME, Smith C, Peat B. Cephalic version by moxibustion for breech presentation. Cochrane Database of Systematic Reviews. 2023;5(5):CD003928. — PubMed PMID: 37158339

Back to Table of Contents

Connections

Back to Table of Contents